Pharmacology - 07:01
Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress
Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress
Career - Sep 20
WCER launches $1.5 million internship study of six Historically Black Colleges and Universities
WCER launches $1.5 million internship study of six Historically Black Colleges and Universities
science wire
« BACK
Pharmacology - Health - 27.02.2019
Health - Pharmacology - 25.02.2019
Health - Pharmacology - 25.02.2019
Pharmacology - Health - 20.02.2019
Pharmacology - Health - 19.02.2019
Health - Pharmacology - 19.02.2019
Pharmacology - 18.02.2019 
Testing pain relief treatments for whiplash
Researchers are investigating the effectiveness of non-opioid pain relief for people with acute whiplash.
Pharmacology - 15.02.2019
Health - Pharmacology - 13.02.2019
Health - Pharmacology - 13.02.2019
Pharmacology - Business / Economics - 13.02.2019 
Redesigning pharmacies with the consumer in mind
Alto Pharmacy uses software and an innovative operations model to improve access to medication. Getting medication to a patient requires coordination between the doctor who writes the prescription, the insurance company that provides coverage, and the pharmacy that ultimately hands over the drug.
Health - Pharmacology - 12.02.2019
Pharmacology - 12.02.2019
Health - Pharmacology - 11.02.2019 
New children’s research facility opens at Imperial
A research facility that aims to improve the quality of life, treatment and care for children with complex diseases formally opened this month.
Health - Pharmacology - 07.02.2019
Pharmacology - Health - 07.02.2019
Life Sciences - Pharmacology - 07.02.2019 
This is a Neuron on Nicotine
When a person takes a puff on a cigarette, nicotine floods into the brain, latching onto receptors on the surface of neurons and producing feelings of happiness.
Pharmacology - Health - 06.02.2019
Health - Pharmacology - 05.02.2019
Health - Pharmacology - 05.02.2019
Pharmacology - Health - 05.02.2019
Pharmacology - Health - 04.02.2019
Pharmacology - Environment - 04.02.2019
Chemistry - Pharmacology - 01.02.2019
Pharmacology - Health - 01.02.2019
Pharmacology - Health - 01.02.2019
Health - Pharmacology - 31.01.2019
Health - Pharmacology - 30.01.2019
Health - Pharmacology - 30.01.2019
Pharmacology - Health - 30.01.2019
Pharmacology - Business / Economics - 30.01.2019
Pharmacology - 29.01.2019
Chemistry - Pharmacology - 28.01.2019
Health - Pharmacology - 23.01.2019
Pharmacology - 22.01.2019
Pharmacology - Life Sciences - 22.01.2019
Health - Pharmacology - 22.01.2019 
Design teams shift their focus to developing recommendations to implement Stanford’s vision for the future
To foster community engagement, the university will create a vision to transform the White Plaza area into a vibrant town center.
Health - Pharmacology - 18.01.2019
Pharmacology - Health - 17.01.2019
Health - Pharmacology - 16.01.2019
Pharmacology - Health - 16.01.2019
Health - Pharmacology - 09.01.2019 
Drug sponge could minimize side effects of cancer treatment
With the help of sponges inserted in the bloodstream to absorb excess drugs, doctors are hoping to prevent the dangerous side effects of toxic chemotherapy agents or even deliver higher doses to knock back tumors, like liver cancer, that don't respond to more benign treatments. The "drug sponge" is an absorbent polymer coating a cylinder that is 3D printed to fit precisely in a vein that carries the blood flowing out of the target organ - the liver in liver cancer, for example.
Life Sciences - Pharmacology - 09.01.2019
Health - Pharmacology - 08.01.2019
Pharmacology - Health - 07.01.2019
Pharmacology - Health - 21.12.2018
Health - Pharmacology - 21.12.2018
Pharmacology - Health - 20.12.2018
Pharmacology - 20.12.2018 
Molecule predicts patient’s ability to survive melanoma
Doctors may be able to assess the survival rates of melanoma patients following the discovery of a molecule that allows the cancer to spread from the skin to other parts of the body.
Business / Economics - Pharmacology - 20.12.2018
Pharmacology
Results 201 - 250 of 1428.
Roche enters into definitive merger agreement to acquire Spark Therapeutics
Roche to acquire Spark Therapeutics for US$ 114.50 per share Spark Therapeutics is a leader in discovering, developing and delivering gene therapies with one commercial asset and four programm
Roche to acquire Spark Therapeutics for US$ 114.50 per share Spark Therapeutics is a leader in discovering, developing and delivering gene therapies with one commercial asset and four programm
FDA grants priority review to Roche’s polatuzumab vedotin in previously treated aggressive lymphoma
Diffuse large B-cell lymphoma is an aggressive type of blood cancer that typically becomes harder to treat each time it returns Polatuzumab vedotin has shown significant potential to improve outcomes
Diffuse large B-cell lymphoma is an aggressive type of blood cancer that typically becomes harder to treat each time it returns Polatuzumab vedotin has shown significant potential to improve outcomes
FDA grants Priority Review to Roche’s personalised medicine entrectinib
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company's New Drug Applications (NDAs) and granted Priority Review for entrectinib for the treatment of adult and
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company's New Drug Applications (NDAs) and granted Priority Review for entrectinib for the treatment of adult and
Researchers are investigating the effectiveness of non-opioid pain relief for people with acute whiplash.
7,000 strokes per year prevented as GPs improve diagnosis and treatment of atrial fibrillation
Around 7,000 strokes each year are being prevented thanks to GPs more than doubling the number of patients at high risk being prescribed with drugs to prevent blood clotting, University of Birmingham researchers have found. Researchers from the University of Birmingham's Institute for Applied Health Research analysed general practice records of five million patients from 2000 to 2016 to find out how many people have a diagnosis of atrial fibrillation and how many are receiving treatment to prevent strokes.
Around 7,000 strokes each year are being prevented thanks to GPs more than doubling the number of patients at high risk being prescribed with drugs to prevent blood clotting, University of Birmingham researchers have found. Researchers from the University of Birmingham's Institute for Applied Health Research analysed general practice records of five million patients from 2000 to 2016 to find out how many people have a diagnosis of atrial fibrillation and how many are receiving treatment to prevent strokes.
Novartis receives FDA approval for Egaten for the treatment of fascioliasis, a neglected tropical disease
Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO Fascioliasis, commonly known as liver fluke infes
Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO Fascioliasis, commonly known as liver fluke infes
Alto Pharmacy uses software and an innovative operations model to improve access to medication. Getting medication to a patient requires coordination between the doctor who writes the prescription, the insurance company that provides coverage, and the pharmacy that ultimately hands over the drug.
£1.5m funding boost for UofG diagnostics spinout
A University of Glasgow spinout which is bringing to market a fast, affordable and efficient new way to diagnose diseases has received a major funding boost.
A University of Glasgow spinout which is bringing to market a fast, affordable and efficient new way to diagnose diseases has received a major funding boost.
GPs and pharmacists don’t have time to involve patients in medication reviews
GPs and pharmacists struggle to find the time to involve patients in medication reviews, despite National Institute for Health and Care Excellence (NICE) guidance advising them to do so, according to a study by researchers at the University of Bristol's Centre for Academic Primary Care.
GPs and pharmacists struggle to find the time to involve patients in medication reviews, despite National Institute for Health and Care Excellence (NICE) guidance advising them to do so, according to a study by researchers at the University of Bristol's Centre for Academic Primary Care.
A research facility that aims to improve the quality of life, treatment and care for children with complex diseases formally opened this month.
In seminar, Tom Lynch talks drug development and improving patient outcomes
New Haven, CT - Dr. Tom Lynch, former Director of Yale Cancer Center and current Chief Scientific Officer at Bristol-Myers Squibb, returned to campus Wednesday to deliver a talk on 'Cancer Drug Discovery: Role of the University/Hospital, Biotech and Pharma to Improve Patient Outcomes.
New Haven, CT - Dr. Tom Lynch, former Director of Yale Cancer Center and current Chief Scientific Officer at Bristol-Myers Squibb, returned to campus Wednesday to deliver a talk on 'Cancer Drug Discovery: Role of the University/Hospital, Biotech and Pharma to Improve Patient Outcomes.
Teaching the immune system to fight cancer
Editor's note: This piece was adapted from a story that originally appeared in the University of Chicago Magazine.
Editor's note: This piece was adapted from a story that originally appeared in the University of Chicago Magazine.
When a person takes a puff on a cigarette, nicotine floods into the brain, latching onto receptors on the surface of neurons and producing feelings of happiness.
Roche submits supplemental biologics license application to the US FDA for Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche's application is being reviewed under the US FDA's Real-Time Oncology Review and Assessment Aid pilot programmes Kadcyla was granted Breakthrough Therapy Designation for this application Ro
Roche's application is being reviewed under the US FDA's Real-Time Oncology Review and Assessment Aid pilot programmes Kadcyla was granted Breakthrough Therapy Designation for this application Ro
New steam treatment offers hope for men with an enlarged prostate
A new treatment for enlarged prostates can reduce side effects and has the potential to improve the lives of thousands of men, says an Imperial expert The treatment, which uses steam, has been shown to shrink prostates by 36 per cent and has fewer side effects than current methods.
A new treatment for enlarged prostates can reduce side effects and has the potential to improve the lives of thousands of men, says an Imperial expert The treatment, which uses steam, has been shown to shrink prostates by 36 per cent and has fewer side effects than current methods.
£45m to train the next generation of global problem solvers
The University of Nottingham has won new funding for five centres that will train the brightest postgraduate researchers to tackle pressing global challenges, and keep the UK at the cutting edge of scientific research.
The University of Nottingham has won new funding for five centres that will train the brightest postgraduate researchers to tackle pressing global challenges, and keep the UK at the cutting edge of scientific research.
First-of-its-kind automatic chemistry facility opens at Imperial
The Centre for Rapid Online Analysis of Reactions (ROAR) is the first national centre for the study of reactions, focusing on data-centric chemistry. ROAR is the flagship Research Facility for the Dial-a-Molecule Grand Challenge , which aims to make the synthesis of any desired molecule ‘as easy as dialling a number'.
The Centre for Rapid Online Analysis of Reactions (ROAR) is the first national centre for the study of reactions, focusing on data-centric chemistry. ROAR is the flagship Research Facility for the Dial-a-Molecule Grand Challenge , which aims to make the synthesis of any desired molecule ‘as easy as dialling a number'.
CHMP recommends EU approval of Roche’s Tecentriq in combination with Avastin and chemotherapy as an initial treatment for lung cancer
Recommendation based on the Phase III IMpower150 study which showed that Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) and chemotherapy (paclitaxel and carboplatin) helped people
Recommendation based on the Phase III IMpower150 study which showed that Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) and chemotherapy (paclitaxel and carboplatin) helped people
CHMP recommends EU approval of Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis in a prospective intra-patient comparison First new class of medicine in nearly 20 years for people wit
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis in a prospective intra-patient comparison First new class of medicine in nearly 20 years for people wit
£10 million gift to drive breakthrough new treatments for myeloma
Imperial College London will establish a new centre for myeloma research at Hammersmith Hospital, thanks to a £10 million donation.
Imperial College London will establish a new centre for myeloma research at Hammersmith Hospital, thanks to a £10 million donation.
New program offers overlooked treatment for addiction
A patient arrives at the hospital with a raging fever and chills radiating throughout his entire body.
A patient arrives at the hospital with a raging fever and chills radiating throughout his entire body.
Better out-of-hours palliative care needed
A better understanding of risks and causes of harm for out of hours palliative care is urgently needed to ensure patient safety, finds a study carried out by researchers at Cardiff University.
A better understanding of risks and causes of harm for out of hours palliative care is urgently needed to ensure patient safety, finds a study carried out by researchers at Cardiff University.
Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) - other company programmes in AD continue
At three years, 88.3% of people treated with Kadcyla in the adjuvant HER2-positive early breast cancer setting did not have their breast cancer return compared to 77.0% treated with Her
At three years, 88.3% of people treated with Kadcyla in the adjuvant HER2-positive early breast cancer setting did not have their breast cancer return compared to 77.0% treated with Her
How do mRNAs deal with stress?
Two hallmarks of the integrated stress response of cells are the inhibition of translation and the formation of stress granules (SGs) and processing bodies (PBs). However, it is not well understood how both processes are coupled. In a study published in Molecular Cell, researchers from the Chao group applied single-molecule RNA imaging to study the interactions of mRNAs with SGs and PBs, and found out that the generally accepted assumptions about the function of granules need to be revised.
Two hallmarks of the integrated stress response of cells are the inhibition of translation and the formation of stress granules (SGs) and processing bodies (PBs). However, it is not well understood how both processes are coupled. In a study published in Molecular Cell, researchers from the Chao group applied single-molecule RNA imaging to study the interactions of mRNAs with SGs and PBs, and found out that the generally accepted assumptions about the function of granules need to be revised.
New name for UofG’s world-changing parasitology research centre
The College of MVLS's Wellcome Centre for Molecular Parasitology has had a name change to better reflect its current world-changing research expertise.
The College of MVLS's Wellcome Centre for Molecular Parasitology has had a name change to better reflect its current world-changing research expertise.
Ers warn online GP consultations need careful implementation
The new NHS 10-year plan launched earlier this month [7 January] states all patients in England will have access to a "digital first primary care offer", such as GP online consultations, by 2022/23.
The new NHS 10-year plan launched earlier this month [7 January] states all patients in England will have access to a "digital first primary care offer", such as GP online consultations, by 2022/23.
To foster community engagement, the university will create a vision to transform the White Plaza area into a vibrant town center.
FDA accepts Roche’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) for Tecentriq (atezolizumab) in combination with Abra
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) for Tecentriq (atezolizumab) in combination with Abra
Personalised treatments for Parkinson’s disease
Scientists at Cardiff University are helping to bring personalised treatments for Parkinson's disease closer to the clinic, thanks to a major investment of over £50,000 from American charity, The Summit for Stem Cell Foundation.
Scientists at Cardiff University are helping to bring personalised treatments for Parkinson's disease closer to the clinic, thanks to a major investment of over £50,000 from American charity, The Summit for Stem Cell Foundation.
With the help of sponges inserted in the bloodstream to absorb excess drugs, doctors are hoping to prevent the dangerous side effects of toxic chemotherapy agents or even deliver higher doses to knock back tumors, like liver cancer, that don't respond to more benign treatments. The "drug sponge" is an absorbent polymer coating a cylinder that is 3D printed to fit precisely in a vein that carries the blood flowing out of the target organ - the liver in liver cancer, for example.
Novartis investigational therapy crizanlizumab (SEG101) receives FDA Breakthrough Therapy designation for the prevention of vaso-occlusive crises in sickle cell disease
Crizanlizumab is a monthly infusion under development to prevent pain crises (also called vaso-occlusive crises, or VOCs) in patients with sickle cell disease Sickle cell VOCs, which are triggered
Crizanlizumab is a monthly infusion under development to prevent pain crises (also called vaso-occlusive crises, or VOCs) in patients with sickle cell disease Sickle cell VOCs, which are triggered
Sandoz and Pear Therapeutics Announce US Launch of reSET-OTM to Help Treat Opioid Use Disorder
ReSET-O(TM)* is the first US FDA-cleared prescription digital therapeutic for patients with Opioid Use Disorder Cleared by the FDA in December, reSET-O is available immediately As part of a broader f
ReSET-O(TM)* is the first US FDA-cleared prescription digital therapeutic for patients with Opioid Use Disorder Cleared by the FDA in December, reSET-O is available immediately As part of a broader f
Novartis receives European Commission (EC) approval for expanded indication for Kisqali (ribociclib)
Basel, December 21, 2018 - Novartis today announced that the European Commission (EC) approved an expanded indication for Kisqali (ribociclib), the CDK4/6 inhibitor with the largest body of first-li
Basel, December 21, 2018 - Novartis today announced that the European Commission (EC) approved an expanded indication for Kisqali (ribociclib), the CDK4/6 inhibitor with the largest body of first-li
Novartis announces offer to acquire CellforCure to expand manufacturing capacity for innovative cell and gene therapies
Proposed acquisition builds on existing agreement with CellforCure for contract manufacturing of Novartis leading CAR-T cell therapy Kymriah (tisagenlecleucel) and recent successful completion of tec
Proposed acquisition builds on existing agreement with CellforCure for contract manufacturing of Novartis leading CAR-T cell therapy Kymriah (tisagenlecleucel) and recent successful completion of tec
Doctors may be able to assess the survival rates of melanoma patients following the discovery of a molecule that allows the cancer to spread from the skin to other parts of the body.
Pharmacology - 07:01
Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress
Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress
Career - Sep 20
WCER launches $1.5 million internship study of six Historically Black Colleges and Universities
WCER launches $1.5 million internship study of six Historically Black Colleges and Universities